A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages (Q6572291)
From MaRDI portal
 | This is the item page for this Wikibase entity, intended for internal use and editing purposes. Please use this page instead for the normal view: A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages |
scientific article; zbMATH DE number 7880930
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | No label defined |
||
| English | A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages |
scientific article; zbMATH DE number 7880930 |
Statements
A Bayesian adaptive design for dual-agent phase I-II oncology trials integrating efficacy data across stages (English)
0 references
15 July 2024
0 references
drug combination
0 references
information borrowing
0 references
meta-analytic-combined
0 references
phase I-II
0 references
seamless designs
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
